SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation - CME
>Registration
>Hotel Information



Officially Endorsed by:

UCSD Sulpizio Cardiovascular Center




American College of Cardiology



Arizona Chapter
California Chapter
Hawaii Chapter
Oregon Chapter
Washington Chapter




The 9th  Annual
International Hawaii Symposium on
Diagnostic and Therapeutic Modalities in Heart Failure
A Comprehensive and Practical Review of Advances in
Heart Failure and Biomarkers


December 5-7, 2019

Waikoloa Beach Marriott
Island of Hawaii

PROGRAM / SCHEDULE

Thursday, December 5, 2019

AM SESSION


6:45am Registration Opens

7:00-8:00 Continental Breakfast

8:00-8:05
Welcome
Barry Greenberg, MD and Alan Maisel, MD

SESSION I
Treating Risk Factors and Use of Biomarkers

Barry Greenberg, MD (Moderator)

8:05-8:30am
Treating Hypertension in 2019 – New Goals and Best Options
Daniel Blanchard, MD

8:30-8:55am
Diabetes - A Cardiovascular Disease: Implications for Therapy with SGLT Inhibitors
Gregg Fonarow, MD

8:55-9:20am
Lowering LDL and Triglycerides to Improve Outcomes
Pam Taub, MD

9:20-9:45AM
What’s New in Biomarkers?
Alan Maisel, MD

9:45-10:05am
Case Presentation
Dr. Blanchard (Presenter) – Drs. Greenberg, Fonarow, Taub, Maisel and Trina Huynh PharmD (Panelists)

10:05-10:30am Break/Visit Exhibits

SESSION II
The Small, Stiff Heart
Alan Maisel, MD (Moderator)

10:30-10:55am
Treating HFpEF – One Size Doesn’t Fit All
Barry Greenberg MD

10:55-11:20am
Hypertrophic Cardiomyopathy – Diagnosis and Treatment
Paul Kim, MD

11:20-11:40am
Amyloidosis I. Diagnosis and Differentiation
Marcus Anthony Urey, MD

11:40am-12:00pm
Amyloidosis II. New Treatment Options for Cardiac and NeurologicalDisease
Marcus Anthony Urey, MD

12:00-1:00pm
Product Theatre Lunch
ONPATTROŽ (patisiran): A Therapy for the Polyneuropathy of
hATTR Amyloidosis in Adults
Support provided by: Alnylam Pharmaceuticals
Marcus Anthony Urey, MD


PM SESSION

SESSION III
Cardiac Rehabilitation, Anti-Coagulation, Atrial Fibrillation
Gregg Fonarow (Moderator)

4:00-4:25pm
Exercise Training and Cardiac Rehabilitation
Pam Taub MD

4:25-4:50pm
DOAC Therapy for CV Disease - AFib and Beyond
Daniel Blanchard, MD

4:50-5:15pm
Managing Atrial Fibrillation - Rate vs Rhythm Control and New Ways to Prevent Stroke
Jonathan Hsu, MD

5:15-5:40pm
Management of Sleep Disordered Breathing
Alan Maisel, MD

5:40-6:00pm
Case Presentation
Dr. Hsu (Presenter) - Drs. Taub, Blanchard, Elkayam, Maisel and Trina Huynh PharmD (Discussants)

Friday, December 6, 2019

AM SESSION


7:00am Registration Opens

SESSION IV
Emerging Concepts and Optimizing Current Therapies
Barry Greenberg, MD (Moderator)

7:45-8:15am
New and Emerging Strategies for Treating Heart Failure
Barry Greenberg, MD

8:15-8:35am
Is There Still a Role for Vasodilator Therapy of Heart Failure?
Uri Elkayam, MD

8:35-8:55am
Neurohormonal Modulation with Sacubitril/Valsartan – Identifying Benefits/Avoiding Pitfalls
Gregg Fonarow, MD

8:55-9:15am
Hyperkalemia in Heart Failure Patients – New Approaches for Therapy
Uri Elkayam, MD

9:15-9:35am
Psychological States and Heart Failure Health
Paul Mills, PhD

9:35-10:00am Case Presentation
Dr. Greenberg (Presenter) – Drs. Elkayam, Fonarow, Urey, Mills and Trina Huynh PharmD (Discussants)

10:00-10:30am Break/Visit Exhibits

SESSION V
Pulmonary Arterial Hypertension (PAH) and Sudden Cardiac Death
Uri Elkayam, MD (Moderator)

10:30-10:50am
Pulmonary Arterial Hypertension– Pathophysiology, Classification and Diagnosis
Paul Kim, MD

10:50-11:10am
Treating Pulmonary Arterial Hypertension
Paul Kim, MD

11:10-11:30am
Preventing Sudden Cardiac Death – Role of ICDs and the WCD
Jonathan Hsu, MD

11:30-12:00pm
Case Vignettes/Audience Q&A
5 minute case presentations by Drs. Kim, Hsu and Elkayam
Panel – Drs. Urey, Hsu, Elkayam and Taub


PM SESSION

SESSION VI
Rare Cause of HF and New Management Strategies
Uri Elkayam MD (Moderator)

4:00-4:25pm
Finding the Zebra in the Haystack – Rare Causes of HF/Role of Genetic Testing
Eric Adler, MD

4:25-4:50pm
Heart Failure and Pregnancy
Uri Elkayam, MD

4:50-5:15pm
The Wearable Revolution – Will New Devices Lead to Better Management?
Pam Taub, MD

5:15-5:40pm
Machine Learning Approaches to Personalizing Medicine
Alan Maisel, MD

5:40-6:00pm
Q&A
Panelists – Drs. Elkayam, Adler, Taub and Maisel

Saturday, December 7, 2019

AM SESSION


7:00am Registration Opens


SESSION VII
Transitioning the HF Patient, Improving Compliance and Managing the Cardiorenal Syndrome
Barry Greenberg, MD (Moderator)

8:00-8:20am
Remote Monitoring of HF Patients - Can We Improve Outcomes?
Gregg Fonarow, MD

8:20-8:40am
Improving Compliance
Trina Huynh, PharmD

8:40-9:10am
Transitioning Patients Following HF Hospitalization
Lorraine Evangelista, PhD

9:10-9:30am
Case Presentation
Dr. Fonarow (Presenter) – Drs. Greenberg, Adler, Evangelista and
Trina Huynh, PharmD (Panelists)

9:30-9:50am Coffee Break/Visit Exhibits

SESSION VIII
Managing End-Stage Heart Failure
Eric Adler, MD (Moderator)

9:50-10:10am
Recognizing Stage D Heart Failure: Implications for Management
Eric Adler, MD

10:10-10:45am
Multidisciplinary Care for Adult Patients with Congenital Heart Disease
Laith Alshawabkeh, MD

10:45-11:05am
Mechanical Circulatory Support for Acute and Chronic Heart Failure
Dipanjan Banerjee, MD

11:05-11:30am Case Presentation
Dr. Adler (Presenter) – Drs. Alshawabkeh, Tsai, Banerjee, and Evangelista (Discussants)

SESSION IX

By Popular Demand

11:30-12:00pm
Third Annual Fascinoma Quiz – Presentation of Cases
Interactive Session with Daniel Blanchard, MD and the Audience

Final Remarks/Adjourn Until 2020